Hyderabad: Ferty9, in partnership with the Indian Fertility Society (IFS), is set to host Fertygyaan 2025, a science-first international conference on reproductive medicine, taking place on 11th and 12th October 2025 at the Marriott Hotel & Convention Centre, Hyderabad. The conference is designed to place gynecologists at the center of the fertility conversation, providing them with the latest scientific insights, practical frameworks, and cross-disciplinary knowledge that bridges research with everyday patient care.
Infertility affects millions of couples worldwide and is increasingly a central concern in women’s health. With changing lifestyles, delayed parenthood, and rising clinical complexities, gynecologists are often the first point of contact for patients. Fertygyaan 2025 addresses the need to bridge the gap between rapidly evolving reproductive science and daily clinical practice, offering a platform where global expertise, innovative research, and practical solutions converge.
The two-day programme will cover a wide range of topics, including personalised ovulation induction, the use of artificial intelligence in embryo assessment, new advances in IVF laboratories, fertility preservation options, genetic testing, male infertility, immune-related challenges in conception, endometriosis and its impact on fertility, recurrent implantation failure, infertility linked to PCOS, and the legal aspects of treatment.
Fertygyaan 2025 promises to empower gynecologists, foster collaboration, and shape new directions for fertility care in India. By bringing together global expertise and India’s leading clinical perspectives, the conference reflects Ferty9’s commitment to advancing patient-centric reproductive medicine and delivering accessible, evidence-based solutions that translate innovation into meaningful outcomes for patients and families.
